Convalescent (immune) plasma treatment in a myelodysplastic covid-19 patient with disseminated tuberculosis

In this report, we aim to convey our experience of multi-task treatment approach with convalescent immune plasma and anti-cytokine drug combination in a COVID-19 patient with extremely challenging comorbidities including active myeloid malignancy, disseminated tuberculosis and kidney failure.

Source: Transfusion and Apheresis Science - May 28, 2020 Category: Hematology Authors: Olgu Erkin Çınar, Başak Sayınalp, Elifcan Aladağ Karakulak, Ayşe Avşar Karataş, Mustafa Velet, Ahmet Çağkan İnkaya, Nazmiye Ebru Ersoy Ortaç, Serpil Öcal, Salih Aksu, İbrahim Celalettin Haznedaroğlu, Nilgün Sayınalp, Osman İlhami Özcebe Tags: Case Report Source Type: research